Related references
Note: Only part of the references are listed.Fast and Accurate Least-Mean-Squares Solvers for High Dimensional Data
Alaa Maalouf et al.
IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2022)
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
Carlotta Antoniotti et al.
LANCET ONCOLOGY (2022)
Neutrophils in cancer: heterogeneous and multifaceted
Catherine C. Hedrick et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Matias Autio et al.
HAEMATOLOGICA (2021)
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
Sara A. Vayrynen et al.
CLINICAL CANCER RESEARCH (2021)
Current treatment and recent progress in gastric cancer
Smita S. Joshi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Hyun Cheol Chung et al.
FUTURE ONCOLOGY (2021)
Paradigms on Immunotherapy Combinations with Chemotherapy
Diego Salas-Benito et al.
CANCER DISCOVERY (2021)
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
D. J. McGrail et al.
ANNALS OF ONCOLOGY (2021)
Putting the Microenvironment into the Immunotherapy Companion Diagnostic
Myrto Moutafi et al.
CLINICAL CANCER RESEARCH (2021)
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma
Dan Liu et al.
EUROPEAN JOURNAL OF CANCER (2021)
Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment
Juha P. Vayrynen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors
Jian Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
Seung Joon Lee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients
Devayani Machiraju et al.
ONCOIMMUNOLOGY (2021)
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial
Maria Di Bartolomeo et al.
ONCOLOGIST (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
Yelena Y. Janjigian et al.
LANCET ONCOLOGY (2020)
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Brian Diskin et al.
NATURE IMMUNOLOGY (2020)
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
Kohei Shitara et al.
JAMA ONCOLOGY (2020)
Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction
Kenji Fujiyoshi et al.
JNCI CANCER SPECTRUM (2020)
Y Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells
Lei Miao et al.
THERANOSTICS (2020)
Response to: 'Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma'
Sascha Rahn et al.
GUT (2019)
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system
Zhi Ji et al.
BMC CANCER (2019)
Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact
Joo Yeon Kim et al.
GASTRIC CANCER (2019)
Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study
John K. Yue et al.
LANCET NEUROLOGY (2019)
Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry
Yu-Kuan Huang et al.
NATURE COMMUNICATIONS (2019)
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
Jean-Christophe Pignon et al.
CLINICAL CANCER RESEARCH (2019)
Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
Chao Lin et al.
GUT (2019)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim et al.
GASTROENTEROLOGY (2018)
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
Elizabeth D. Thompson et al.
GUT (2017)
Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
Ting-ting Wang et al.
GUT (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)